Aesthetic nurse prescriber Anna Baker discusses multi-modality approaches to addressing tissue changes with glucagon-like peptide-1 agonists and glucose-dependent insulinotropic polypeptide therapies Current literature suggests that medical aesthetic practitioners are noticing an increase in demand from patients seeking treatments to counteract …
To access this post, you must purchase Aesthetics Journal Subscriptions – AJ Print & Digital Subscriber or Aesthetics Journal Subscriptions – AJ Digital Subscriber.
log in
log in
